Clarithromycin inhibits NF-κB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 1, 2001, Pages 44-47

  Ichiyama, T ^a   Nishikawa, M ^a   Yoshitomi, T ^a   Hasegawa, S ^a   Matsubara, T ^a   Hayashi, T ^a   Furukawa, S ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CLARITHROMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL LINE; LUNG ALVEOLUS EPITHELIUM; MONONUCLEAR CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANTI-BACTERIAL AGENTS; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CLARITHROMYCIN; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; LUNG; MONOCYTES; NF-KAPPA B; PLASMIDS; STAPHYLOCOCCAL PROTEIN A; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035165393     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.1.44-47.2001     Document Type: Article

References (42)

1. Erythromycin inhibits transcriptional activation of NF-κB, but not NFAT, through calcineurin-independent signaling in T cells
2. Function and activation of NF-κB in the immune system
3. The NF-κB and IκB proteins: New discoveries and insights
4. Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice
5. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation
6. Interleukin-4 inhibits κ light chain expression and NFκB activation but not IκBα degradation in 70Z/3 murine pre-B cells
7. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB
8. A sensitive method for the detection of β-galactosidase in transfected mammalian cells
9. Clinical studies on clarithromycin dry syrup in the pediatric field. Pediatric Study Group of TE-031 Dry Syrup
10. The inducible transcription factor NF-κB: Structure-function relationship of its protein subunits
11. Rapid proteolysis of IκB-α is necessary for activation of transcriptional factor NF-κB
12. Characterization of a functional NF-κB site in the human interleukin 1β promoter: Evidence for a positive autoregulatory loop
13. The levels of clarithromycin and 14-hydroxy metabolite in the lung
14. Anti-inflammatory activity of macrolide antibiotics
15. α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation
16. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB
17. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6
18. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13
19. Activation of interleukin-6 gene expression through the NF-κB transcription factor
20. Pyrrolidine dithiocarbamate prevents I-κB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs
21. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-κB activation in T lymphocytes
22. IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis
23. α-Melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents
24. Cyclosporin A interferes with the inducible degradation of NF-κB inhibitor, but not with the processing of p105/NF-κB1 in T cells
25. Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells
26. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8
27. Effects of erythromycin on experimental extrinsic allergic alveolitis
28. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro
29. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB
30. Comparison of bronchopulmonary pharmacokinetics of clarithomycin and azithromycin
31. An essential role for NF-κB in human CD34+ bone marrow cell survival
32. Inflammation and repair processes in chronic obstructive pulmonary disease
33. Morphine modulates NFκB activation in macrophages
34. Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro
35. Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood
36. Regulatory elements involved in Tax-mediated transactivation of the HTLV-1 LTR
37. Inflammatory mechanisms in neonatal chronic lung disease
38. Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages
39. Estrogen inhibits phorbol ester-induced IκBα transcription and protein degradation
40. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells
41. Erythromycin suppresses interleukin 6 expression by human bronchial cells: A potential mechanism of its anti-inflammatory action
42. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β